Staging and assessing trophoblastic tumors. A possible solution to an intractable problem.
The present situation of staging gestational trophoblastic tumors by the system of the International Federation of Obstetrics and Gynecology (FIGO) and of scoring systems of risk factors in such tumors is examined critically. A solution for resolving staging and scoring difficulties is offered by combining the present FIGO staging with the accepted standardized World Health Organization system.
Kohorn
E I
EI
Yale Trophoblast Center, Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut 06520-8063, USA.
D000328:Adult; D000367:Age Factors; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D011247:Pregnancy; D011379:Prognosis; D012307:Risk Factors; D014328:Trophoblastic Neoplasms / Q000473:pathology*; D014594:Uterine Neoplasms / Q000473:pathology*; D014944:World Health Organization